Secreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention.
Ontology highlight
ABSTRACT: Progressive fibrosis is a pathological hallmark of many chronic diseases responsible for organ failure. Although there is currently no therapy on the market that specifically targets fibrosis, the dynamic fibrogenic process is known to be regulated by multiple soluble mediators that may be therapeutically intervened. The failing hamster heart exhibits marked fibrosis and increased expression of secreted Frizzled-related protein 2 (sFRP2) amenable to reversal by mesenchymal stem cell (MSC) therapy. Given the previous demonstration that sFRP2-null mice subjected to myocardial infarction exhibited reduced fibrosis and improved function, we tested whether antibody-based sFRP2 blockade might counteract the fibrogenic pathway and repair cardiac injury. Cardiomyopathic hamsters were injected intr
SUBMITTER: Mastri M
PROVIDER: S-EPMC3948976 | biostudies-literature | 2014 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA